Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.
Wallace S, Guo DC, Regalado E, Mellor-Crummey L, Bamshad M, Nickerson DA, Dauser R, Hanchard N, Marom R, Martin E, Berka V, Sharina I, Ganesan V, Saunders D, Morris SA, Milewicz DM.
Wallace S, et al. Among authors: martin e.
Clin Genet. 2016 Oct;90(4):351-60. doi: 10.1111/cge.12739. Epub 2016 Feb 18.
Clin Genet. 2016.
PMID: 26777256
Free PMC article.